Propiedades Fucicort combina la potente acci6n t6pica, antibacteriana del inflamatorio de la betametasona. El valerato de betametasona es tfas inflamatorias; aun condiciones refractarias se tratan frecuent Aplicado t0picamente el ,~cido fus~dico resulta eficaz contra est; ciertas especies de Clostridium y Bacteriodes. La presencia de I del acido fusidico. Indicaciones Fucicort est,~ indicado para el tratamiento de las dermatopatfas una infeccion bacteriana. Las dermatopatias inflamatorias incJ estasis; dermatitis seborreica; dermatitis por contacto; liquen sim Dosificacion Lesiones sin ap6sito: 2-3 veces al dia. Lesiones con ap6sito: Aplicaciones menos frecuentes pueden s Contraindicaciones Los corticosteroides t6picos est~n contraindicados en las infecc dermatitis perioral; la acn6 ros~cea y la condici6n ulcerosa. Hipersensibilidad a cualquiera de los componentes. Precauciones La terapia a largo plazo debe evitarse, sobre todo en la cara, en f ~flamatorias, en las cuales existe o puede presentarse yen: eccema at6pico; eccema discoide; eccema por ~e cr6nico; psoriasis; lupus eritematoso discoide. ' suficientes. nes fungosas, virales y tuberculosas de la piel; en la xuras yen zones intertriginosas, esi como en infantes en el embarazo - se hah observado anomali'as fetales Composition Each gramme contains: Fusidic acid 20 mg Betamethasone as valerate 1 mg Preserved with chlorocresol Properties Fucicort combines the potent topical antibacterial a of betamethasone. Betamethasone valerate is a topic conditions can often be t~eated succesfully. When applied topically, fusidic acid is effective agai Clostridia and Bacteroides. The antibacterial activity Indications Fucicort is indicated in inflammatory dermatoses dermatoses include atopic eczema, discoid eczem simples chronicus, psoriasis, discoid lupus erythem Dosage Uncovered lesions: 2-3 daily applications. Covered lesions: Less frequent application m Contra-indications Topical corticosteroides are contra-indicated in viral acea and ulcerative condition. :tion of fusidic acid with the anti-inflammatory and antipruritic effects ~1 steroid with rapid effect in inflammatory dermatoses. Even refractory ~st Staphylococci, Streptococci, Corynebacteria, Neisseria and certain )f fusidic acid is not diminished in the presence of betamethasone. vhere bacterial infection is present or likely to occur. Inflammatory 3, stasis eczema, seborrhoeic dermatitis, contact dermatitis, lichen ItOSUS. ay be adequate. tuberculous and fungal skin infections, perioral dermatitis, acne ros- the face, on flexures, and intertrigenous areas, and in lely in pregnancy - fetal abnormalities have been seen Gal corticosteroids, prolonged and intensive treatment inning and dilatation of the superficial blood vessels, 'e involved. Systemic absorption, sufficient to produce ,d or extensive use, especially when used under eye. Glaucoma might be the result if the preparation THIS IS A MEDICAMENT - Medicament is a product, but not like others products - Medicament is a product which affects your health, ar - Follow strictly the Doctor's prescription, the method medicament. The Doctor and Pharmacist are experts i - Do not by yourself interrupt the period of treatment pm Do not repeat the same medicament and do not incre Do not leave medicament within reach of children Council of Arab Health Ministers Union of Arab Pharmacists ~cido fusfdico con los efectos antipruriginoso y ar ]n esteroide t6pico con efecto r~pido en las dermatol~ mente con exito. filococos, estreptococos, Corynebacterium, Neisseria etametasona no disminuye la actividad antibacteria~ , (;omposiciOn Cada gramo contiene: Acido fusfdico 20 mg Betametasona en forma de valerato 1 mg ~ cion sistemica. )bservado con poca frecuencia. Tal tensivo puede causar cambios atr6fi ; sanguineos superficales, particular suficiente para producir hiperadren ri prolongada o extensa, sobre todo nihos est~n expuestos a riesgo. ,~ t6pico cerca del ojo debe hacerse a. )DUCTS JAMARCA ~ ! .... l ...... ~ ..... r"' ........ Precautions Long-term continuous therapy should be avoided, particularly ir infants and children. Topical steroids should not be used extensi in animals due to systemic absorption. Adverse reactions Hypersensitivity has rarely been encountered. As with other to[; may cause local atrophic changes of the skin, such as striae, ti particularly when occlusive dressing is used or when skin folds hypercorticism/adrenal suppression, can occur with prolong occlusion/napkin. Infants and children are particularly at risk. Caution should be exercised if a topical steroid is used near th~ enters the eye. como es el caso con otros corticosteroides t6picos, el :os locales de la piel, entre otros: estrias, delgadez de la ~ente si se utiliza un vendaje oclusivo o si hay pliegues )corticismo/supresi6n adrenal, puede presentarse como ~ajo vendaje oclusivo. :on cautela, ya que la introd~de la preparaci6n en 004197-02 y nifios. Los esteroides t6pi( en animales debidas a absom Efectos secundarios La hipersensibilidad se ha~ tratamiento prolongado e in piel y dilataci6n de los vaso~ de piel. Absorci6n sist6mica consecuencia de la aplicaci6 Especialmente los infantes ~ La aplicaci6n de un esteroid el ojo puede causar glaucorr LEO PHARMACEUTICAL PR( BALLERUP- DENMARK- DII
